Catalyst

Slingshot members are tracking this event:

Mylan Launches Generic Crestor Tablets

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MYL

100%

Additional Information

Additional Relevant Details Mylan announced the U.S. launch of Rosuvastatin Calcium Tablets, 5 mg, 10 mg, 20 mg and 40 mg, which is a generic version of AstraZeneca's Crestor. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Rosuvastatin Calcium Tablets are used in combination with diet for the treatment of high triglycerides (hypertriglyceridemia) in adults.
http://newsroom.myla...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 20, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Crestor Tablets, Generics, Rosuvastatin Calcium Tablets